SP140
Basic information
Region (hg38): 2:230203110-230313215
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SP140 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 33 | 41 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 33 | 7 | 4 |
Variants in SP140
This is a list of pathogenic ClinVar variants found in the SP140 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-230207972-T-C | Hepatic veno-occlusive disease-immunodeficiency syndrome | Likely benign (Nov 19, 2023) | ||
2-230207977-T-C | Hepatic veno-occlusive disease-immunodeficiency syndrome | Conflicting classifications of pathogenicity (Oct 11, 2023) | ||
2-230207990-C-T | Uncertain significance (May 24, 2019) | |||
2-230207994-C-T | Hepatic veno-occlusive disease-immunodeficiency syndrome • not specified | Benign (Feb 01, 2024) | ||
2-230208002-CT-C | Hepatic veno-occlusive disease-immunodeficiency syndrome | Pathogenic (Nov 01, 2022) | ||
2-230208009-T-C | Hepatic veno-occlusive disease-immunodeficiency syndrome | Uncertain significance (Nov 01, 2022) | ||
2-230208012-T-A | Hepatic veno-occlusive disease-immunodeficiency syndrome | Likely pathogenic (Jan 27, 2014) | ||
2-230208012-T-C | Hepatic veno-occlusive disease-immunodeficiency syndrome | Uncertain significance (Aug 15, 2022) | ||
2-230208022-T-C | Hepatic veno-occlusive disease-immunodeficiency syndrome | Likely benign (Jun 20, 2023) | ||
2-230208041-C-A | Hepatic veno-occlusive disease-immunodeficiency syndrome | Uncertain significance (Apr 08, 2022) | ||
2-230208041-C-G | Hepatic veno-occlusive disease-immunodeficiency syndrome | Uncertain significance (Aug 30, 2021) | ||
2-230208047-T-C | Hepatic veno-occlusive disease-immunodeficiency syndrome | Uncertain significance (Jul 19, 2022) | ||
2-230208057-T-C | Hepatic veno-occlusive disease-immunodeficiency syndrome | Uncertain significance (Jan 03, 2023) | ||
2-230208057-T-G | Inborn genetic diseases | Uncertain significance (Dec 12, 2023) | ||
2-230208071-G-T | Hepatic veno-occlusive disease-immunodeficiency syndrome | Likely benign (Oct 14, 2023) | ||
2-230208078-GT-G | Hepatic veno-occlusive disease-immunodeficiency syndrome | Benign (Jun 26, 2022) | ||
2-230209916-A-G | Hepatic veno-occlusive disease-immunodeficiency syndrome | Conflicting classifications of pathogenicity (Apr 30, 2023) | ||
2-230209917-A-G | Hepatic veno-occlusive disease-immunodeficiency syndrome | Likely benign (Mar 04, 2023) | ||
2-230209921-C-T | Hepatic veno-occlusive disease-immunodeficiency syndrome | Uncertain significance (Jan 12, 2018) | ||
2-230209934-T-C | Hepatic veno-occlusive disease-immunodeficiency syndrome | Uncertain significance (Oct 17, 2022) | ||
2-230209946-G-T | Hepatic veno-occlusive disease-immunodeficiency syndrome | Uncertain significance (May 13, 2022) | ||
2-230209958-C-A | Hepatic veno-occlusive disease-immunodeficiency syndrome | Uncertain significance (Dec 08, 2021) | ||
2-230209980-A-G | Hepatic veno-occlusive disease-immunodeficiency syndrome | Likely benign (Jul 26, 2022) | ||
2-230210007-C-G | Inborn genetic diseases | Uncertain significance (Jun 21, 2023) | ||
2-230210491-G-A | Mycobacterium tuberculosis, susceptibility to | Uncertain significance (Apr 01, 2007) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SP140 | protein_coding | protein_coding | ENST00000392045 | 27 | 155937 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.00e-8 | 1.00 | 125716 | 0 | 32 | 125748 | 0.000127 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.787 | 407 | 454 | 0.896 | 0.0000228 | 5738 |
Missense in Polyphen | 93 | 134.63 | 0.69077 | 1838 | ||
Synonymous | 1.12 | 146 | 164 | 0.889 | 0.00000920 | 1494 |
Loss of Function | 4.00 | 22 | 53.6 | 0.410 | 0.00000254 | 688 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000443 | 0.000427 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000112 | 0.000109 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000151 | 0.000149 |
Middle Eastern | 0.000112 | 0.000109 |
South Asian | 0.0000655 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the nuclear body, also known as nuclear domain 10, PML oncogenic domain, and KR body (PubMed:8910577). May be involved in the pathogenesis of acute promyelocytic leukemia and viral infection (PubMed:8910577). May play a role in chromatin-mediated regulation of gene expression although it does not bind to histone H3 tails (PubMed:24267382). {ECO:0000269|PubMed:24267382, ECO:0000269|PubMed:8910577, ECO:0000303|PubMed:8910577}.;
Recessive Scores
- pRec
- 0.0622
Intolerance Scores
- loftool
- 0.699
- rvis_EVS
- 0.32
- rvis_percentile_EVS
- 72.8
Haploinsufficiency Scores
- pHI
- 0.0278
- hipred
- N
- hipred_score
- 0.214
- ghis
- 0.479
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.730
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sp140
- Phenotype
Gene ontology
- Biological process
- regulation of transcription, DNA-templated;defense response
- Cellular component
- fibrillar center;nucleus;nuclear envelope;nucleoplasm;mitochondrion;PML body
- Molecular function
- DNA binding;DNA-binding transcription factor activity;protein binding;metal ion binding